CAMBRIDGE, Mass. --
InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that the Company is the Title Sponsor of the 8th annual Working 2 Walk Science & Advocacy Symposium taking place September 27-28, 2013 at the Boston Convention & Exhibit Center in Boston, MA.
Said Frank Reynolds, InVivo Chief Executive Officer, “We are proud to once again be a part of the Working 2 Walk symposium. At the event we will provide an update on our human study, and will also discuss how we’re leveraging our materials to develop multiple tissue engineered and tissue regeneration products to treat a range of neurotrauma conditions.”
InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that the Company is the Title Sponsor of the 8th annual Working 2 Walk Science & Advocacy Symposium taking place September 27-28, 2013 at the Boston Convention & Exhibit Center in Boston, MA.
Said Frank Reynolds, InVivo Chief Executive Officer, “We are proud to once again be a part of the Working 2 Walk symposium. At the event we will provide an update on our human study, and will also discuss how we’re leveraging our materials to develop multiple tissue engineered and tissue regeneration products to treat a range of neurotrauma conditions.”
Looks like people will have the opportunity to confront these
frauds. But, I'd bet that most of our armchair scientists will
show a little bit more appreciation for them in person.
Comment